BMS-986419
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986419, covering 2025-11-17 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants [Phase 1]